The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 11, 2018
Filed:
Jul. 24, 2017
Applicant:
Astrazeneca Ab, Södertälje, SE;
Inventors:
James Stewart Scott, Cambridge, GB;
Thomas Andrew Moss, Cambridge, GB;
Daniel Hillebrand O'Donovan, Cambridge, GB;
Johannes Wilhelmus Maria Nissink, Cambridge, GB;
Samantha Jayne Hughes, Cambridge, GB;
Bernard Christophe Barlaam, Cambridge, GB;
Dan Anders Broo, Mölndal, SE;
Bin Yang, Waltham, MA (US);
Jeffrey Gilbert Varnes, Waltham, MA (US);
Dedong Wu, Waltham, MA (US);
Assignee:
AstraZeneca AB, Sodertalje, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61K 31/407 (2006.01); A61K 31/495 (2006.01); A61K 31/506 (2006.01); G01N 23/20 (2018.01); G01N 25/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/407 (2013.01); A61K 31/495 (2013.01); A61K 31/506 (2013.01); C07D 471/04 (2013.01); G01N 23/20075 (2013.01); G01N 25/4866 (2013.01);
Abstract
The specification relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.